LH · Categories · Form 4
LH - SEC Form 4 insider transactions
Labcorp Holdings Inc. (LH) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for LH
- SEC Form 4 filed by Schechter Adam H4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Graham Anita Z4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Schroeder Mark S4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Caveney Brian J4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Wilkinson Peter J4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Vaughn Bryan T4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Van Der Vaart Sandra D4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Summy Amy B.4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Oyegunwa Akinbolade4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Meltzer Jonathan C4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Kyle Kathryn W4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Bailey Megan D.4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- President & CEO Schechter Adam H sold $2,437,047 worth of shares (8,705 units at $279.96), decreasing direct ownership by 10% to 80,773 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Corporate Affairs Van Der Vaart Sandra D sold $156,000 worth of shares (548 units at $284.91), decreasing direct ownership by 18% to 2,579 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Pres of ED, CMO & CSO Caveney Brian J sold $429,458 worth of shares (1,500 units at $286.31), decreasing direct ownership by 5% to 30,107 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SVP, Chief Accounting Officer Wilkinson Peter J sold $185,108 worth of shares (666 units at $277.94), decreasing direct ownership by 26% to 1,852 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Chief Marketing Officer Summy Amy B. converted options into 230 shares and covered exercise/tax liability with 83 shares, increasing direct ownership by 3% to 5,722 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SVP, Chief Accounting Officer Wilkinson Peter J converted options into 696 shares and covered exercise/tax liability with 206 shares, increasing direct ownership by 24% to 2,518 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Chief Financial Officer, EVP Wang Julia Aijun covered exercise/tax liability with 245 shares and converted options into 860 shares, increasing direct ownership by 51% to 1,817 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Diagnostics Vaughn Bryan T converted options into 323 shares and covered exercise/tax liability with 93 shares, increasing direct ownership by 4% to 5,613 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Corporate Affairs Van Der Vaart Sandra D converted options into 376 shares and covered exercise/tax liability with 99 shares, increasing direct ownership by 10% to 3,126 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Pres Diagnostics & COO Schroeder Mark S converted options into 806 shares and covered exercise/tax liability with 259 shares, increasing direct ownership by 9% to 6,473 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- President & CEO Schechter Adam H sold $1,499,536 worth of shares (5,273 units at $284.38), converted options into 3,656 shares and covered exercise/tax liability with 1,521 shares, decreasing direct ownership by 3% to 89,478 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, CIO & CTO Oyegunwa Akinbolade converted options into 230 shares and covered exercise/tax liability with 68 shares, increasing direct ownership by 4% to 4,106 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Operations Meltzer Jonathan C converted options into 243 shares, covered exercise/tax liability with 70 shares and sold $25,267 worth of shares (87 units at $290.42), increasing direct ownership by 3% to 2,782 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Chief Legal Officer Kyle Kathryn W converted options into 216 shares and covered exercise/tax liability with 62 shares, increasing direct ownership by 5% to 3,442 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, CHRO Graham Anita Z converted options into 356 shares and covered exercise/tax liability with 109 shares, increasing direct ownership by 20% to 1,460 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Pres of ED, CMO & CSO Caveney Brian J covered exercise/tax liability with 211 shares and converted options into 740 shares, increasing direct ownership by 2% to 31,607 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Pres, Central Labs & Intl Bailey Megan D. converted options into 403 shares and covered exercise/tax liability with 138 shares, increasing direct ownership by 7% to 4,148 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Rothman Paul converted options into 897 shares, increasing direct ownership by 54% to 2,571 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Wengel Kathryn E converted options into 897 shares, increasing direct ownership by 28% to 4,133 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Parham Richelle P converted options into 897 shares, increasing direct ownership by 36% to 3,366 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Neupert Peter M converted options into 897 shares, increasing direct ownership by 7% to 13,784 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Kong Garheng converted options into 897 shares, increasing direct ownership by 7% to 13,739 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Kliphouse Kirsten Marie converted options into 897 shares, increasing direct ownership by 40% to 3,160 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Davis Jeffrey A. converted options into 897 shares, increasing direct ownership by 20% to 5,460 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Anderson Kerrii B converted options into 897 shares, increasing direct ownership by 10% to 9,563 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by President & CEO Schechter Adam H4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Operations Meltzer Jonathan C sold $25,188 worth of shares (91 units at $276.79), decreasing direct ownership by 3% to 2,696 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP, Chief Legal Officer Kyle Kathryn W4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP, Diagnostics Vaughn Bryan T4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Chief Financial Officer, EVP Wang Julia Aijun4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by SVP, Chief Accounting Officer Wilkinson Peter J4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP, CIO & CTO Oyegunwa Akinbolade4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP, Chief Marketing Officer Summy Amy B.4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP, CHRO Graham Anita Z4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP, Pres, Central Labs & Intl Bailey Megan D.4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP, Pres of ED, CMO & CSO Caveney Brian J4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Director Kong Garheng4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Director Rothman Paul4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Director Sampson John H4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Director Wengel Kathryn E4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Director Parham Richelle P4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Director Neupert Peter M4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Director Kliphouse Kirsten Marie4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Director Davis Jeffrey A.4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Director Bulto Carulla Victor4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Director Anderson Kerrii B4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Chief Financial Officer, EVP Wang Julia Aijun converted options into 893 shares and covered exercise/tax liability with 254 shares, increasing direct ownership by 113% to 1,202 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Pres of ED, CMO & CSO Caveney Brian J converted options into 1,298 shares and covered exercise/tax liability with 389 shares, increasing direct ownership by 3% to 31,078 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)